Pharmaceutical Commerce - September/October 2013 - (Page 6)

4 editorial Table of Contents Getting to the ‘hub’ of the matter 7 op-ed Almost half of all prescribers have restrictions on pharma rep access ZS Associates report finds oncologists the most restrictive, with 65% placing moderate-to-severe limits Supreme court: reverse payment settlements subject to antitrust scrutiny What are the risks of future ‘pay for delay’ settlements between branded and generic manufacturers? Worldwide, pharma distribution is moving to a serial-coded basis Regardless of how pending US legislation is resolved, manufacturers need to move ahead 8 Fedex offers a 96-hour, zero-pre-conditioning package for cold chain shipments NanoCool technology needs neither batteries nor dry ice/gel packs for 2–8°C shipping Symphony technology Group picks up Ubc assets from express Scripts Symphony also tangles with IMS Health over business practices top News multiple sclerosis, diabetes and migraine are therapy areas where alternative drug delivery is sought Survey of physicians, patients points to transdermal patches and nasal delivery as preferred methods, says Frost & Sullivan HHS office of Inspector General finds continuing problems in federal provider-identification databases Will inaccuracies in the National Plan and Provider Enumeration System (NPPES) create headaches for pharma? Packaging coordinators rebrands its Andersonbrecon acquisition, expands production capacity Blister and bottle packaging, and cold chain distribution, are current investment targets big three wholesalers round out their independentpharmacy meetings with new business announcements Cardinal Health’s Retail Business Conference, ABC’s ThoughtSpot and McKesson’s IdeaShare meetings gather up independent pharmacists Pain-management market grows, but resistance to new abuse-deterrent technologies is widespread Data Resources study finds mixed reaction to new formulations—and little optimism for new drugs; meanwhile, abuse problems remain a public health concern Veeva buys AdvantagemS, building out its foundation for healthcare-provider master data Acquisition brings millions of provider listings into the Veeva Network, along with validation services and territoryalignment software model N offers tools for managing international reference pricing Cloud-based system will enable global pricing managers to analyze regulatory trends and simulate the effects of pricing changes 12 business/Finance A conversation with John m. Gray, Healthcare Distribution management Assn. more analytic firepower is being directed at the US medication-adherence problem 14 brand marketing & communications biomarkers and companion diagnostics expand drug potential Essential for approving some new products, biomarkers are becoming integrated with patient therapies covance builds out its managed-markets advisory service Company will provide services to manage data and terms of sales contracts 18 HUb report Finding the ‘HUb’ in Specialty Pharma Services For specialty pharmaceuticals, the connection between manufacturer, payer and patient is the rising crop of hub services 24 Information technology Protect your software investment with ‘training as a Service’ (taaS) Why cloud-based software applications require a new training model 26 Supply chain/Logistics ProDUct SecUrItY rePort: Pharma track-and-trace inches closer to reality Come September, all eyes will be on federal legislation that is close to final passage take an enterprise view on serialization 30 Legal & regulatory the dynamic evolution of multi-sponsor remS Risk Evaluation & Mitigation Strategy (REMS) programs are evolving, with new complexities for compliance managers 32 manufacturing & Packaging A growing preference for ready-to-administer vaccines: new guidelines, evidence, and trends Vaccine administration is shifting from multidose vials to prefilled syringes for a host of important safety and economic considerations 35 6 Visit our website at www.Pharmaceuticalcommerce.com September | October 2013 meetings and editorial Index VOL. 8, NO. 5 Founder and editor in chief Nicholas Basta, 718 282 6112 nbasta@pharmaceuticalcommerce.com contributing editors Lena Anthony, F.J. Quinn, Bob Sperber, Suzanne Shelley, Peggy Wright editorial board Jeffrey Berkowitz, Walgreens Richard Carlson, Blue Fin Group Liz Coyle, IMS Health Adam Fein, Pembroke Consulting Rich Minoff, 1 Global Partners Mark Seitz, Eli Lilly & Co. Robert Zachow, Bracco Diagnostics Advertising Sales Senior Vice President and Publisher Clifford P. Tallman, Jr., 203 831 0771 ctallman@pharmaceuticalcommerce.com New england Vince Cavaseno, 617 232 2000 vcavaseno@pharmaceuticalcommerce.com Jody Estabrook, 774 283 4528 jestabrook@pharmaceuticalcommerce.com midwest David Gerchen, 314 878 3939 dgerchen@pharmacueticalcommerce.com Southeast Cathy Williams, 843 410 2739, ext. 101 cwilliams@pharmaceuticalcommerce.com West Richard Ayer, 949 366 9089 rayer@pharmaceuticalcommerce.com Advertising and editorial Production Advertising: Heidi Nelson, 203 852 6570, ext. 228 hnelson@pharmaceuticalcommerce.com Editorial Layout: Media Ventures, Inc. www.mediaventuresinc.com circulation and Administration Senior Vice President and General manager David Soskin, 203 831 0711 dsoskin@pharmaceuticalcommerce.com reprints, research and custom Publishing David Soskin, 203 831 0711 dsoskin@pharmaceuticalcommerce.com circulation Subscription changes Jennifer Lee, 800 437 7456 jennifer.lee@emscirc.com Healthcare commerce media corporation Pharmaceutical Commerce is published by Healthcare Commerce Media Corp. 85 Westminster Rd., Brooklyn, NY 11218. editorial/Advertising Queries: 718 282 6112, or info@pharmaceuticalcommerce.com Copyright 2013. All rights reserved. Printed in the United States of America. Send all subscription inquiries or requests to Subscriptions, Pharmaceutical Commerce, 151 Fairchild Avenue, Plainview, NY 11808-1709, Tel: 800 437 7456. Fax: 516 908 3802 The management and editors of Pharmaceutical Commerce make every effort to publish accurate information. However, neither the management, editorial board, editors or reporters can be held liable for erroneous information. Opinions of Pharmaceutical Commerce columnists are their own, and do not necessarily represent those of employees or other contributors to Pharmaceutical Commerce. www.PharmaceuticalCommerce.com http://www.mediaventuresinc.com http://www.PharmaceuticalCommerce.com http://www.PharmaceuticalCommerce.com

Table of Contents for the Digital Edition of Pharmaceutical Commerce - September/October 2013

Contents

Pharmaceutical Commerce - September/October 2013

https://www.nxtbook.com/nxtbooks/pharmcomm/202006
https://www.nxtbook.com/nxtbooks/pharmcomm/202003
https://www.nxtbook.com/nxtbooks/pharmcomm/201911
https://www.nxtbook.com/nxtbooks/pharmcomm/201909
https://www.nxtbook.com/nxtbooks/pharmcomm/201906
https://www.nxtbook.com/nxtbooks/pharmcomm/201903
https://www.nxtbook.com/nxtbooks/pharmcomm/201811
https://www.nxtbook.com/nxtbooks/pharmcomm/201809
https://www.nxtbook.com/nxtbooks/pharmcomm/201806
https://www.nxtbook.com/nxtbooks/pharmcomm/20180304
https://www.nxtbook.com/nxtbooks/pharmcomm/20171112
https://www.nxtbook.com/nxtbooks/pharmcomm/20170910
https://www.nxtbook.com/nxtbooks/pharmcomm/20170708
https://www.nxtbook.com/nxtbooks/pharmcomm/20170506
https://www.nxtbook.com/nxtbooks/pharmcomm/20170304
https://www.nxtbook.com/nxtbooks/pharmcomm/20170102
https://www.nxtbook.com/nxtbooks/pharmcomm/20161112
https://www.nxtbook.com/nxtbooks/pharmcomm/20160910
https://www.nxtbook.com/nxtbooks/pharmcomm/20160708
https://www.nxtbook.com/nxtbooks/pharmcomm/20160506
https://www.nxtbook.com/nxtbooks/pharmcomm/20160304
https://www.nxtbook.com/nxtbooks/pharmcomm/20160102
https://www.nxtbook.com/nxtbooks/pharmcomm/20151112
https://www.nxtbook.com/nxtbooks/pharmcomm/20150910
https://www.nxtbook.com/nxtbooks/pharmcomm/20150708
https://www.nxtbook.com/nxtbooks/pharmcomm/20150506
https://www.nxtbook.com/nxtbooks/pharmcomm/20150304
https://www.nxtbook.com/nxtbooks/pharmcomm/20150102
https://www.nxtbook.com/nxtbooks/pharmcomm/20141112
https://www.nxtbook.com/nxtbooks/pharmcomm/coldchaindirectory2014
https://www.nxtbook.com/nxtbooks/pharmcomm/20140910
https://www.nxtbook.com/nxtbooks/pharmcomm/20140708
https://www.nxtbook.com/nxtbooks/pharmcomm/20140506
https://www.nxtbook.com/nxtbooks/pharmcomm/20140304
https://www.nxtbook.com/nxtbooks/pharmcomm/20140102
https://www.nxtbook.com/nxtbooks/pharmcomm/dataservicedirectory
https://www.nxtbook.com/nxtbooks/pharmcomm/20131112
https://www.nxtbook.com/nxtbooks/pharmcomm/20130910_hubreport
https://www.nxtbook.com/nxtbooks/pharmcomm/20130910
https://www.nxtbook.com/nxtbooks/pharmcomm/20130708
https://www.nxtbook.com/nxtbooks/pharmcomm/20130506
https://www.nxtbook.com/nxtbooks/pharmcomm/coldchain2013
https://www.nxtbook.com/nxtbooks/pharmcomm/20130304
https://www.nxtbook.com/nxtbooks/pharmcomm/20130102
https://www.nxtbook.com/nxtbooks/pharmcomm/20121112
https://www.nxtbook.com/nxtbooks/pharmcomm/20120910
https://www.nxtbook.com/nxtbooks/pharmcomm/20120708
https://www.nxtbook.com/nxtbooks/pharmcomm/20120506
https://www.nxtbook.com/nxtbooks/pharmcomm/20120506_coldchain
https://www.nxtbook.com/nxtbooks/pharmcomm/20120304
https://www.nxtbook.com/nxtbooks/pharmcomm/20120102
https://www.nxtbook.com/nxtbooks/pharmcomm/20111112
https://www.nxtbook.com/nxtbooks/pharmcomm/20110910
https://www.nxtbook.com/nxtbooks/pharmcomm/20110708
https://www.nxtbook.com/nxtbooks/pharmcomm/20110506
https://www.nxtbook.com/nxtbooks/pharmcomm/20110304
https://www.nxtbook.com/nxtbooks/pharmcomm/20110102
https://www.nxtbook.com/nxtbooks/pharmcomm/20101112
https://www.nxtbook.com/nxtbooks/pharmcomm/20100910
https://www.nxtbook.com/nxtbooks/pharmcomm/20100708
https://www.nxtbook.com/nxtbooks/pharmcomm/20100506
https://www.nxtbook.com/nxtbooks/pharmcomm/201004
https://www.nxtbook.com/nxtbooks/pharmcomm/201003
https://www.nxtbook.com/nxtbooks/pharmcomm/20100102
https://www.nxtbook.com/nxtbooks/pharmcomm/20091112
https://www.nxtbookmedia.com